Aeglea BioTherapeutics to Present New Interim Phase 1/2 Clinical Trial Data in Arginase 1 Deficiency at 2018 ASHG Annual Meeting
Aeglea BioTherapeutics, Inc. (AGLE)
Last aeglea biotherapeutics, inc. earnings: 8/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.aegleabio.com/investor-overview
Company Research
Source: GlobeNewswire
Company to Host Clinical Update Conference Call on October 17 at 8:30 a.m. ET Aeglea to Present Literature Review on Arginase 1 Deficiency Positive Preclinical Efficacy Data on its AEB4104 Homocystinuria Therapeutic Program AUSTIN, Texas, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer, today announced it will present new interim Phase 1/2 clinical trial data demonstrating clinical improvement in patients with Arginase 1 Deficiency at the 2018 American Society of Human Genetics (ASHG) Annual Meeting being held October 16 – 20 in San Diego, California. The Company will hold a clinical update conference call on October 17 at 8:30 a.m. ET to discuss these developments. Title: Improvements in Arginase 1 Deficiency-related disease manifestations following plasma arginine reduction with pegzilarginase:
Show less
Read more
Impact Snapshot
Event Time:
AGLE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGLE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGLE alerts
High impacting Aeglea BioTherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics